In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they plan to reclassify marijuana for a Plan III drug. This rescheduling will recognize that cannabis has genuine healthcare purposes and may help open up the door to analysis on other potential remedy employs. Some critics dilemma whether or not companies https://josueskcwl.blogsvila.com/35407467/a-review-of-cannabis-high-experience